OSR HEALTH, INC. Increase (Decrease) in Inventories
OSR HEALTH, INC. (OSRH) reported Increase (Decrease) in Inventories of $210.42 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInInventories · last filed 2026-08-14
- OSR HEALTH, INC. increase (decrease) in inventories for the quarter ending 2026-06-30 was $144.89K.
- OSR HEALTH, INC. increase (decrease) in inventories for the quarter ending 2026-03-31 was $65.54K.
- OSR HEALTH, INC. increase (decrease) in inventories for the quarter ending 2025-12-31 was $20.90K.
- OSR HEALTH, INC. increase (decrease) in inventories for the quarter ending 2025-09-30 was -$11.82K, a 108.06% decline year-over-year.
- OSR HEALTH, INC. increase (decrease) in inventories for fiscal 2025 was -$763.73K.
- OSR HEALTH, INC. increase (decrease) in inventories for fiscal 2024 was -$305.60K.
| Period end | Increase (Decrease) in Inventories 3 month | Increase (Decrease) in Inventories 3 month as first filed | Increase (Decrease) in Inventories 6 month | Increase (Decrease) in Inventories 9 month | Increase (Decrease) in Inventories 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | $144.89K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $210.42K 10-Q · filed 2026-08-14 | $231.32K derived: sum of 3 quarters · filed 2026-08-14 | $219.50K derived: sum of 4 quarters · filed 2026-08-14 | |
| 2026-03-31 | $65.54K 10-Q · filed 2026-05-13 | $86.43K derived: sum of 2 quarters · filed 2026-05-13 | $74.61K derived: sum of 3 quarters · filed 2026-05-13 | -$508.73K derived: sum of 4 quarters · filed 2026-08-14 | |
| 2025-12-31 | $20.90K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $9.08K derived: sum of 2 quarters · filed 2026-03-31 | -$574.27K derived: sum of 3 quarters · filed 2026-08-14 | -$763.73K 10-K · filed 2026-03-31 | |
| 2025-09-30 | -$11.82K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | -$595.17K derived: sum of 2 quarters · filed 2026-08-14 | -$784.63K 10-Q · filed 2025-11-12 | -$818.29K derived: sum of 4 quarters · filed 2026-08-14 | |
| 2025-06-30 | -$583.35K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | -$772.81K 10-Q · filed 2026-08-14 | -$806.47K derived: sum of 3 quarters · filed 2026-08-14 | -$659.73K derived: sum of 4 quarters · filed 2026-08-14 | |
| 2025-03-31 | -$189.47K 10-Q · filed 2026-05-13 | -$189.47K 10-Q · filed 2025-05-20 | -$223.12K derived: sum of 2 quarters · filed 2026-05-13 | -$76.39K derived: sum of 3 quarters · filed 2026-05-13 | -$284.65K derived: sum of 4 quarters · filed 2026-05-13 |
| 2024-12-31 | -$33.66K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $113.08K derived: sum of 2 quarters · filed 2026-03-31 | -$95.19K derived: sum of 3 quarters · filed 2026-03-31 | -$305.60K 10-K · filed 2026-03-31 | |
| 2024-09-30 | $146.74K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | -$61.53K derived: sum of 2 quarters · filed 2025-11-12 | -$271.94K 10-Q · filed 2025-11-12 | ||
| 2024-06-30 | -$208.26K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | -$418.68K 10-Q · filed 2025-08-14 | |||
| 2024-03-31 | -$210.42K 10-Q · filed 2025-05-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |